BellRing Brands (NYSE:BRBR) Now Covered by Analysts at Goldman Sachs Group

Share on StockTwits

Goldman Sachs Group began coverage on shares of BellRing Brands (NYSE:BRBR) in a report released on Monday, Briefing.com Automated Import reports. The brokerage issued a buy rating and a $24.00 price target on the stock.

Several other equities research analysts have also recently weighed in on the company. Morgan Stanley assumed coverage on BellRing Brands in a research report on Monday. They issued an overweight rating and a $21.00 price objective for the company. Barclays assumed coverage on BellRing Brands in a research report on Monday. They issued an overweight rating and a $22.00 price objective for the company. Finally, DA Davidson assumed coverage on BellRing Brands in a research report on Monday, October 14th. They issued a buy rating for the company. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. BellRing Brands currently has a consensus rating of Buy and an average price target of $21.36.

Shares of BRBR traded up $0.04 during mid-day trading on Monday, hitting $19.26. The company’s stock had a trading volume of 314,200 shares, compared to its average volume of 827,655. BellRing Brands has a one year low of $15.15 and a one year high of $19.75.

BellRing Brands Company Profile

BellRing Brands, Inc manufactures and sells nutrition products in the United States and internationally. The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, powders, and nutrition bars and supplements. It offers its products primarily under the Premier Protein, Dymatize, and PowerBar, as well as Joint Juice and Supreme Protein brands.

Featured Article: What does an inverted yield curve signify?

Analyst Recommendations for BellRing Brands (NYSE:BRBR)

Receive News & Ratings for BellRing Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BellRing Brands and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.